Bargain hunters are wise to pay careful attention to insider buying, because although there are many various reasons for an insider to sell a stock, presumably the only reason they would use their hard-earned cash to make a purchase, is that they expect to make money.
Today we look at two noteworthy recent insider buys.
Bargain hunters are wise to pay careful attention to insider buying, because although there are many various reasons for an insider to sell a stock, presumably the only reason they would use their hard-earned cash to make a purchase, is that they expect to make money.
Today we look at two noteworthy recent insider buys.
At Applied Therapeutics, a filing with the SEC revealed that on Friday, Director Stacy J.
Kanter purchased 6,500 shares of APLT, for a cost of $22.86 each, for a total investment of $148,590.
Kanter was up about 7.0% on the buy at the high point of today's trading session, with APLT trading as high as $24.46 in trading on Wednesday.
Applied Therapeutics is trading up about 9.1% on the day Wednesday.
And on Monday, Director Joseph P.
Beebe purchased $99,104 worth of Univest Financial, purchasing 4,000 shares at a cost of $24.78 each.
Univest Financial is trading up about 1.3% on the day Wednesday.
So far Beebe is in the green, up about 5.4% on their purchase based on today's trading high of $26.11.